Perpustakaan Universitas Padjajaran
Pencarian Spesifik

Detail Cantuman

No image available for this title

Text  

Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand

DAFTAR ISI

PART A LIFECYCLE MANAGEMENT BUSINESS ENVIRONMENT 1
1. Challenges facing the branded drug industry 3-26

2. ...

  • CodeCallNoLokasiKetersediaan
    01021120500053Tersedia
  • Perpustakaan
    Fakultas Farmasi
    Judul Seri
    -
    No. Panggil
    338.5 Ell P
    Penerbit Jhon Wiley & Sons, Inc : New Jersey.,
    Deskripsi Fisik
    xxii, 389 hal. : ilus. ; 25 cm Index. Hal. 371-389
    Bahasa
    Indonesia
    ISBN/ISSN
    978-0-470-48753-2
    Klasifikasi
    338.5 Ell P
    Tipe Isi
    -
    Tipe Media
    -
    Tipe Pembawa
    -
    Edisi
    NULL
    Subyek
    Pharmaceutical
    Drug Industry
    Ellery, Tony I
    Hansen, Neal
    Info Detil Spesifik
    -
    Pernyataan Tanggungjawab
  • DAFTAR ISI

    PART A LIFECYCLE MANAGEMENT BUSINESS ENVIRONMENT 1
    1. Challenges facing the branded drug industry 3-26

    2. The Life cycle of industries, technologies, and brands 30-36

    3. The Life cycle of a pharmaceutical brand 38-46

    PART B LIFECYCLE MANAGEMENT REGULATORY AND LEGAL ENVIRONMENT 55
    4. The Generic approval process 57-61
    5. Hatch-waxman legislation and its effects on LCM 62-66
    6. U.S. Health-care reform 2010 69
    7. European sector inquiry 72

    PART C PATENTS AND EXCLUSIVITIES 77
    8. Patents and other intellectual property rights 79-96
    9. Nonpatent exclusivities 99-105
    10. Patent settlements 107

    PART D DEVELOPMENTAL LCM 113
    11. Strategic principles of developmental LCm 115-121
    12. Indication expansion and sequencing 123
    13. Ptient subpopulations and personalized medicine 131-139
    14. New dosage strengths, new dosage regimens 140-141
    15. Reformulation, new routes of administration, and drug delivery 143-149
    16. Fixed-dose combinations (FDCs) and co-packaging 152
    17. Second-generation products and modified chemistry 159-163
    18. Other development LCm strategies 165-166

    PART E COMMERCIAL LCM 167
    19. Strategic principles of commercial LCm 169-171
    20. Geographical expansion and optimization 172-175
    21. OTC switching 178-184
    22. Barnd loyalty and service programs 186
    23. Strategic pricing strategies 190-193
    24. Generic strategic and tacties 198-202
    25. Exit strategies 204-206

    PART F BIOLOGICS AND BIOSIMILARS 207
    26. Biologies and LCm 209-215
    27. Biosimilars and their impact on biologic LCM 217-231

    PART G THE INTEGRATED BRAND LCM STRATEGY AND ITS IMPLEMENTATION 233
    28. Strategic goals of LCM brand plans 235-237
    29. Ten keys to successful LCM 238-252
    30. Organizational structures and systems for ensuring successful LCM 254-266
    31. The LCM process: description, timing, and participants 268-271

    PART H INTEGRATING LCM WITH PORTFOLIO MANAGEMENT 277
    32. Principles of portfolio management 279
    33. LCM projects in the development portfolio 284
    34. Managing established brand portfolios 286-290

  • Tidak tersedia versi lain

  • Silakan login dahulu untuk melihat atau memberi komentar.


//

Informasi